Supplementary Table 1 from Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
crossref（2023）
摘要
Table S1. Clinical information of the 46 AML patients who provided AML cells for in vitro or in vivo assays.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要